Screening potential FDA-approved inhibitors of the SARS-CoV-2 major protease 3CL(pro) through high-throughput virtual screening and molecular dynamics simulation

por Liu, Wen-Shan, Li, Han-Gao, Ding, Chuan-Hua, Zhang, Hai-Xia, Wang, Rui-Rui, Li, Jia-Qiu
Publicado 2021